128 related articles for article (PubMed ID: 38000279)
41. WDFY2 Potentiates Hepatic Insulin Sensitivity and Controls Endosomal Localization of the Insulin Receptor and IRS1/2.
Zhang L; Li X; Zhang N; Yang X; Hou T; Fu W; Yuan F; Wang L; Wen H; Tian Y; Zhang H; Lu X; Zhu WG
Diabetes; 2020 Sep; 69(9):1887-1902. PubMed ID: 32641353
[TBL] [Abstract][Full Text] [Related]
42. Insulin‑receptor substrate 1 protects against injury in endothelial cell models of ox‑LDL‑induced atherosclerosis by inhibiting ER stress/oxidative stress‑mediated apoptosis and activating the Akt/FoxO1 signaling pathway.
Liu J; Yi X; Tao Y; Wang Y; Xu Z
Int J Mol Med; 2020 Nov; 46(5):1671-1682. PubMed ID: 33000267
[TBL] [Abstract][Full Text] [Related]
43. Prenylated flavonoid fractions from Glycyrrhiza glabra alleviate insulin resistance in HepG2 cells by regulating the ERK/IRS-1 and PI3K/Akt signaling pathways.
Li D; Fan J; Du L; Ren G
Arch Pharm Res; 2024 Feb; 47(2):127-145. PubMed ID: 38267702
[TBL] [Abstract][Full Text] [Related]
44. Oat β-D-glucan ameliorates type II diabetes through TLR4/PI3K/AKT mediated metabolic axis.
Guo H; Wu H; Hou Y; Hu P; Du J; Cao L; Yang R; Dong X; Li Z
Int J Biol Macromol; 2023 Sep; 249():126039. PubMed ID: 37516222
[TBL] [Abstract][Full Text] [Related]
45. Dioscin attenuates high‑fat diet‑induced insulin resistance of adipose tissue through the IRS‑1/PI3K/Akt signaling pathway.
Li H; Yu L; Zhao C
Mol Med Rep; 2019 Feb; 19(2):1230-1237. PubMed ID: 30483735
[TBL] [Abstract][Full Text] [Related]
46. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice.
Irimia JM; Meyer CM; Segvich DM; Surendran S; DePaoli-Roach AA; Morral N; Roach PJ
J Biol Chem; 2017 Jun; 292(25):10455-10464. PubMed ID: 28483921
[TBL] [Abstract][Full Text] [Related]
47. The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism.
Summers SA; Kao AW; Kohn AD; Backus GS; Roth RA; Pessin JE; Birnbaum MJ
J Biol Chem; 1999 Jun; 274(25):17934-40. PubMed ID: 10364240
[TBL] [Abstract][Full Text] [Related]
48. Downregulating SOCS3 with siRNA ameliorates insulin signaling and glucose metabolism in hepatocytes of IUGR rats with catch-up growth.
Ye J; Zheng R; Wang Q; Liao L; Ying Y; Lu H; Cianflone K; Ning Q; Luo X
Pediatr Res; 2012 Dec; 72(6):550-9. PubMed ID: 23007031
[TBL] [Abstract][Full Text] [Related]
49. Links between oral microbiome and insulin resistance: Involvement of MAP kinase signaling pathway.
Chang YR; Cheng WC; Hsiao YC; Su GW; Lin SJ; Wei YS; Chou HC; Lin HP; Lin GY; Chan HL
Biochimie; 2023 Nov; 214(Pt B):134-144. PubMed ID: 37442534
[TBL] [Abstract][Full Text] [Related]
50. Baicalein improves glucose metabolism in insulin resistant HepG2 cells.
Yang Z; Huang W; Zhang J; Xie M; Wang X
Eur J Pharmacol; 2019 Jul; 854():187-193. PubMed ID: 30970232
[TBL] [Abstract][Full Text] [Related]
51. Polydatin Improves Glucose and Lipid Metabolisms in Insulin-Resistant HepG2 Cells through the AMPK Pathway.
Hao J; Huang K; Chen C; Liang Y; Wang Y; Zhang X; Huang H
Biol Pharm Bull; 2018; 41(6):891-898. PubMed ID: 29863077
[TBL] [Abstract][Full Text] [Related]
52. Resistin induces insulin resistance, but does not affect glucose output in rat-derived hepatocytes.
Liu F; Yang T; Wang B; Zhang M; Gu N; Qiu J; Fan HQ; Zhang CM; Fei L; Pan XQ; Guo M; Chen RH; Guo XR
Acta Pharmacol Sin; 2008 Jan; 29(1):98-104. PubMed ID: 18158871
[TBL] [Abstract][Full Text] [Related]
53. PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.
Xia N; Tang Z; Wang C; Xu G; Nie X; Zhang W; Zhao Y; Wang S; Zhu X; Cui S
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):116-22. PubMed ID: 26002461
[TBL] [Abstract][Full Text] [Related]
54. Loureirin B attenuates insulin resistance in HepG2 cells by regulating gluconeogenesis signaling pathway.
Ding Y; Xia S; Fang H; Niu B; Chen Q
Eur J Pharmacol; 2021 Nov; 910():174481. PubMed ID: 34481876
[TBL] [Abstract][Full Text] [Related]
55. Krüppel-like factor 14 increases insulin sensitivity through activation of PI3K/Akt signal pathway.
Yang M; Ren Y; Lin Z; Tang C; Jia Y; Lai Y; Zhou T; Wu S; Liu H; Yang G; Li L
Cell Signal; 2015 Nov; 27(11):2201-8. PubMed ID: 26226221
[TBL] [Abstract][Full Text] [Related]
56. IRS-1/PI3K/Akt pathway and miRNAs are involved in whole grain highland barley (
Deng N; Guo R; Zheng B; Li T; Liu RH
Food Funct; 2020 Nov; 11(11):9535-9546. PubMed ID: 33104141
[TBL] [Abstract][Full Text] [Related]
57. Paeoniflorin suppresses lipid accumulation and alleviates insulin resistance by regulating the Rho kinase/IRS-1 pathway in palmitate-induced HepG2Cells.
Ma Z; Liu H; Wang W; Guan S; Yi J; Chu L
Biomed Pharmacother; 2017 Jun; 90():361-367. PubMed ID: 28380411
[TBL] [Abstract][Full Text] [Related]
58. Disruption of the Phosphate Transporter Pit1 in Hepatocytes Improves Glucose Metabolism and Insulin Signaling by Modulating the USP7/IRS1 Interaction.
Forand A; Koumakis E; Rousseau A; Sassier Y; Journe C; Merlin JF; Leroy C; Boitez V; Codogno P; Friedlander G; Cohen I
Cell Rep; 2016 Sep; 16(10):2736-2748. PubMed ID: 27568561
[TBL] [Abstract][Full Text] [Related]
59. C-Phycocyanin inhibits hepatic gluconeogenesis and increases glycogen synthesis via activating Akt and AMPK in insulin resistance hepatocytes.
Ren Z; Xie Z; Cao D; Gong M; Yang L; Zhou Z; Ou Y
Food Funct; 2018 May; 9(5):2829-2839. PubMed ID: 29693104
[TBL] [Abstract][Full Text] [Related]
60. Lipopolysaccharide impairs insulin sensitivity via activation of phosphoinositide 3-kinase in adipocytes.
Wakayama S; Haque A; Koide N; Kato Y; Odkhuu E; Bilegtsaikhan T; Naiki Y; Komatsu T; Yoshida T; Yokochi T
Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):145-9. PubMed ID: 24506665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
